Skip to main content

Advertisement

Log in

Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers

  • Brief Report
  • Published:
Archives of Virology Aims and scope Submit manuscript

Abstract

Thirty-two participants, aged between 3-18 years, born to hepatitis B surface antigen (HBsAg)-positive mothers and vaccinated at birth were analyzed for hepatitis B virus (HBV) infection. Overall, 56% had anti-HB titers ≥10 IU/L; five were positive for antibodies to the core antigen (anti-HBc), and two of these were also positive for HBsAg/DNA. One of the HBsAg/anti-HBc double-negative children presented with an unusual occult infection (HBV DNA-positive). No known vaccine escape mutations were detectable. Our data suggest that the vaccine protected 93.8% of children in this high-risk group against chronic HBV infection. Occult infections should be considered even in countries with low endemicity and high vaccination coverage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ (2015) Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386(10003):1546–1555

    Article  PubMed  Google Scholar 

  2. Centers for Disease Control and Prevention (CDC) (2012) Post vaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008–2011. MMWR Morb Mortal Wkly Rep 28(61):768–771

    Google Scholar 

  3. Anuario Estadístico de Salud 2015 (2016) Dirección Nacional de Registros Médicos y Estadísticas de salud. La Habana. http://files.sld.cu/dne/files/2016/04/Anuario_2015_electronico-1.pdf. Accessed 1 June 2016

  4. Carman WF (1997) The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 4(Suppl. 1):11–20

    Article  PubMed  Google Scholar 

  5. Rodríguez L, Bello M, Delgado G, Gutiérrez A, Díaz M, Montalvo MC, Sariego S, Pedroso P, Sánchez A (2006) Eficacia de la inmunización en lactantes de alto riesgo de infección por el VHB. Experiencia cubana. Rev Saludarte 4(3):188–193

    Google Scholar 

  6. Delgado G, Galindo MA, Rodríguez L, Díaz M (2003) Vaccination strategies against hepatitis B and their results: Cuba and the United States, 2003. MEDICC Rev V(1). http://www.medicc.org/publications/medicc_review/1004/pages/cuban_medical_literature.html

  7. Bello M, Rodríguez L, Delgado G, Díaz M, Montalvo MC, Gutiérrez A (2004) Vigilancia de los hijos de madres positivas al antígeno de superficie de hepatitis B, 2000–2002. Rev Cubana Med Trop 56(1):31–34

    Google Scholar 

  8. Bello M, Rodríguez L, Rodríguez D, Montalvo MC, Pedroso P, Sariego S, Sánchez M (2016) Infección oculta por el virus de la hepatitis B en hijos de madres positivas al HBsAg. VacciMonitor 25(1):12–18

    Google Scholar 

  9. Rodríguez L, Montalvo MC, Sariego S, Bello M, Mora E, Kourí V, Martínez PA, Sánchez M, Marrero B (2012) Reacción en cadena de la polimerasa en tiempo real para la cuantificación del ADN del virus de la hepatitis B. Rev Cubana Med Trop 64(3)

  10. Olinger CM, Venard V, Njayou M, Oyefolu AO, Maiga I, Kemp AJ, Omilabu SA, Le Faou A, Muller CP (2006) Phylogenetic analysis of the precore/core gene of hepatitis B virus genotypes E and A in West Africa: new subtypes, mixed infections and recombinations. J Gen Virol 87:1163–1173

    Article  CAS  PubMed  Google Scholar 

  11. Magnius LO, Norder H (1995) Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 38:24–34

    Article  CAS  PubMed  Google Scholar 

  12. Wang Y, Chen T, Lu L, Wang M, Wang D, Yao H, Fan C, Qi J, Zhang Y, Qu C (2017) Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults. Vaccine 35(7):1064–1070

    Article  CAS  PubMed  Google Scholar 

  13. Muzio González V, Cinza Estévez Z, Ortega Tápanes A, Véliz Ríos G, Galindo MA, Delgado G, Díaz M, Rodríguez L, Bravo J, Pedroso Flaquet P et al (2001) Post-licensing studies of the Cuban anti-hepatitis B vaccine, Heberbiovac-HB. Biotecnología Aplicada 18(2):103–104

    Google Scholar 

  14. Bracciale L, Fabbiani M, Sansoni A, Luzzi L, Bernini L, Zanelli G (2009) Impact of hepatitis B vaccination in children born to HBsAg-positive mothers: a 20 years retrospective study. Infection 37(4):340–343

    Article  CAS  PubMed  Google Scholar 

  15. Roznovsky L, Orsagova I, Kloudova A, Tvrdik J, Kavieszova L, Lochman I, Mrasek J, Hozakova L, Zjevikova A, Pliskova L (2010) Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up. Infection 38(5):395–400

    Article  CAS  PubMed  Google Scholar 

  16. Shahmoradi S, Yahyapour Y, Mahmoodi M, Alavian SM, Fazeli Z, Jazayeri SM (2012) High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG. J Hepatol 57:515–521

    Article  PubMed  Google Scholar 

  17. Foaud H, Maklad S, Mahmoud F, El-Karaksy H (2015) Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis. Infection 43(3):307–314

    Article  CAS  PubMed  Google Scholar 

  18. Su H, Zhang Y, Xu D, Wang B, Zhang L, Li D, Xiao D, Li F, Zhang J, Yan Y (2013) Occult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China. PLoS One 8(8):e70768

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Pande C, Sarin K, Patra S, Kumar A, Mishra S, Srivastava S, Bhutia K, Gupta E, Mukhopadhyay CK, Dutta AK, Trivedi SS (2013) Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial. J Viral Hepat 20(11):801–810

    CAS  PubMed  Google Scholar 

  20. Sadeghi A, Yahyapour Y, Poortahmasebi V, Shahmoradi S, Roggendorf M, Karimzadeh H, Alavian SM, Jazayeri SM (2015) Clearance of HBV DNA in immunized children born to HBsAg-positive mothers, years after being diagnosed with occult HBV infection. J Viral Hepat 1–4

Download references

Acknowledgements

The authors want to acknowledge Dr. Verena Muzio from the Center for Genetic Engineering and Biotechnology for her valuable comments. Also, the authors are grateful for the support of the Cuban Program for the Control and Prevention of hepatitis viruses. For the work done in Luxembourg we acknowledge the financial support of the Ministry of Foreign and European Affairs.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Licel de los Angeles Rodríguez Lay.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rodríguez Lay, L., Bello Corredor, M., Montalvo Villalba, M.C. et al. Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers. Arch Virol 162, 2393–2396 (2017). https://doi.org/10.1007/s00705-017-3365-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00705-017-3365-6

Keywords

Navigation